Enhanced expression of PP1γ1, a catalytic subunit isoform of protein phosphatase type1 and expression of telomerase activity in Ewing's sarcoma cells

Research Communications in Molecular Pathology and Pharmacology

Volumn 113-114, Issue , 2003, Pages 269-274

  Mori, Satoshi ^a   Cao, Yongping ^a   Yamada, Takahisa ^b   Sogawa, Kenichi ^c   Kondo, Kazuya ^c   Hino, Norifumi ^d   Miyazaki, Tatsuhiko ^d   Kawaguchi, Yoji ^a   Oka, Shiro ^a   Kawasaki, Kojiro ^a   Mashiba, Tasuku ^a   Norimatsu, Hiromichi ^a  

^a KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ewing's sarcoma; Expression of PP1 1 and telomerase activity; Malignancy of osteogenic tumors; Osteosarcoma and chondrosarcoma; PP1 1; Telomerase activity; Telomerase activity regulation by protein phosphorylation

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1GAMMA1; PHOSPHOPROTEIN PHOSPHATASE 2A; TELOMERASE; UNCLASSIFIED DRUG; PHOSPHOPROTEIN PHOSPHATASE;

ARTICLE; CATALYSIS; CHONDROSARCOMA; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SUBUNIT; EWING SARCOMA; HUMAN; HUMAN TISSUE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

CHONDROSARCOMA; HUMANS; OSTEOSARCOMA; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; SARCOMA, EWING'S; TELOMERASE;

EID: 13144258736     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ambros, I.M., Ambros, P.F., Strehl, S., Kovar, H., Gadner, H. and Salzer-Kuntschik, M. (1991) MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer, 7:1886-1893
2. Autexier, C. and Greider, C.W.(1996) Telomerase and cancer: revisiting the teromere hypothesis. Trends Biochem.Sci.,21:387-391
3. Dehner, L.P.(1986)Peripheral and central primitive neuroectodermal tumors. Arch. Pathol. Lab. Med.,110:997-1005
4. Dehner, L.P.(1993) Primitive Neuroectodermaltumor and Ewing's sarcoma. Am. J. Surg. Pathol.,17:1-13
5. MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing' sarcoma of bone. Am. J. Surg. Pathol., 16:746-755
6. Kim, N.W. and Fred, W.(1997) Advanced in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol(TRAP). Nucleic Acids Res., 25:2595-2597
7. Li, H., Zhao, L.L., Funder, J.W. and Liu, J.P.(1997) Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem., 272,16729-16732
8. Morin, G.B. (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59:521-529
9. Rorke, L.B.(1983) The cerebellar meduloblastoma and its relationship to primitive neuroectodermal tumors. J. Neuropathol Exp. Neurol., 42:1-15
10. Sasaki, K., Shima, H., Kitagawa, Y., Irino, S., Sugimura, T. and Nagao, M. (1990) Identification of members of the protein phosphatase 1gene family in the rat and enhanced expression of protein phosphatase 1α gene in rat hepatocellular carcinomas. Jpn. J. Cancer Res., 81:1272-1280
11. Shima, H., Hatano, Y., Chun, Y., Sugimura, T., Zhang, Z., Lee, E.Y.G. and Nagao, M. (1993) Identification of PP1 catalytic subunits PP1γ1, PP1δ, and PP1αin various rat tissues. Biochem. Biophys. Res. Commun., 192, 1289-1296.
12. Sogawa, K., Yamada,T., Oka, S., Kawasaki, K., Mori, S., Tanaka, H., Norimatsu, H., Cai, Y., Kuwabara, H., Shima, H., Nagao, M. and Matsumoto, K. (1995) Enhanced expression of catalytic subunit isoform PP1γ1 of protein phosphatase type 1 associated with malignancy of osteogenic tumor. Cancer Lett.,89,1-6
13. Sogawa, K., Yamada, T., Sugita, A., Kito, K., Tachibana, M., Nezu, K. and Ueda, N. (1996) Role of protein phosphatase in malignant osteogenic and soft tissue tumors.Res. Commun. Molec. Pathol. Pharmacol., 93,33-42